Study examines cardiovascular safety of Pfizer bivalent COVID-19 vaccineResults show no difference in risk of stroke, myocardial infarction or pulmonary embolism with Pfizer monovalent versus Pfizer bivalent COVID-19 boosters. New guidance on using Vaxneuvance (15-valent) pneumococcal vaccine in childrenNational Advisory Committee on Immunization issues interim guidance on the use of Vaxneuvance in children and its interchangeability with Prevnar 13. What risk factors appear associated with getting long-COVID? Meta-analysis examines demographic characteristics and comorbidities associated with an increased risk of developing post-COVID-19 condition. POP QUIZ: Pneumococcal vaccines in adults Based on the latest NACI guidance document, all the following recommendations are true, EXCEPT for . . . Superbug fungus cases rose dramatically during pandemic The fungus, Candida auris, is a form of yeast that is usually not harmful to healthy people but can be a deadly risk to fragile hospital and nursing home patients. Are outpatients with COVID-19 at higher risk of venous thromboembolism? New study assessed the risk and identified risk factors for the development of venous thromboembolism among outpatients with COVID-19. H5N1 virus: Skunks found dead in Metro Vancouver had avian flu The World Health Organization has said that H5N1 infection in humans can cause severe disease and has a high death rate. What frontline pharmacists need to know about preventing and treating COVID-19 Thrombosis Canada is offering two free live accredited webinars for frontline pharmacists. POP QUIZ: Spring COVID booster for adults Test your knowledge of the latest NACI guidance. Report says long COVID could impact economy and be ‘mass disabling event’ in Canada A report released Thursday by Canada’s chief science adviser says she considers COVID-19 the “head” of the pandemic but long COVID its “tail.” First Previous 32 33 34 35 36 Next Last
